rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Eliot Forster

Director

Company insider

Files Form 4 as: Director, Protalix BioTherapeutics, Inc. (DE); Director, Immatics; President and CEO, F-star Therapeutics.

Every Form 4 they filed

In numbers

Trades disclosed
24
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
3
Companies where not an officer
2
First trade
20 Nov 2020
Last trade
3 Sep 2026
Last filed
4 Sep 2026

Companies traded

Where they are an officer
F-star TherapeuticsDirector, Officer · last 8 Mar 20230 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
PLX Protalix BioTherapeutics, Inc. (DE)Director · Biotechnology · last 3 Sep 20260 buys · 0 sells
IMTX ImmaticsDirector · Biotechnology · last 16 Jun 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
3 Sep 2026filed 4 Sep 2026PLX Protalix BioTherapeutics, Inc. (DE)option or derivative · BiotechnologySEC FORM 4 Code A—17,000 at $0.00filing
3 Sep 2026filed 4 Sep 2026PLX Protalix BioTherapeutics, Inc. (DE)option or derivative · BiotechnologySEC FORM 4 Code A—8,500 at $0.00filing
3 Sep 2026filed 4 Sep 2026PLX Protalix BioTherapeutics, Inc. (DE)option or derivative · BiotechnologySEC FORM 4 Code A—17,000 at $0.00filing
3 Sep 2026filed 4 Sep 2026PLX Protalix BioTherapeutics, Inc. (DE)option or derivative · BiotechnologySEC FORM 4 Code A—8,500 at $0.00filing
16 Jun 2026filed 18 Jun 2026IMTX Immaticsoption or derivative · BiotechnologySEC FORM 4 Code A—48,000 at $0.00filing
16 Jun 2026filed 18 Jun 2026IMTX Immaticsoption or derivative · BiotechnologySEC FORM 4 Code A—48,000 at $0.00filing
3 Sep 2025filed 4 Sep 2025PLX Protalix BioTherapeutics, Inc. (DE)option or derivative · BiotechnologySEC FORM 4 Code A—15,000 at $0.00filing
3 Sep 2025filed 4 Sep 2025PLX Protalix BioTherapeutics, Inc. (DE)BiotechnologySEC FORM 4 Code A—7,500filing
14 Sep 2023filed 15 Sep 2023PLX Protalix BioTherapeutics, Inc. (DE)option or derivative · BiotechnologySEC FORM 4 Code A—85,715 at $0.00filing
8 Mar 2023filed 9 Mar 2023F-star Therapeuticsoption or derivativeSEC FORM 4 Code D—127,924filing
8 Mar 2023filed 9 Mar 2023F-star Therapeuticsoption or derivativeSEC FORM 4 Code D—165,028filing
8 Mar 2023filed 9 Mar 2023F-star Therapeuticsoption or derivativeSEC FORM 4 Code D—126,909filing
8 Mar 2023filed 9 Mar 2023F-star TherapeuticsSEC FORM 4 Code U$2.5M347,578 at $7.12filing
8 Mar 2023filed 9 Mar 2023F-star TherapeuticsSEC FORM 4 Code D$527K73,959 at $7.12filing
29 Jul 2022filed 2 Aug 2022F-star Therapeuticsoption or derivativeSEC FORM 4 Code M—32,602 at $0.00filing
29 Jul 2022filed 2 Aug 2022F-star Therapeuticsoption or derivativeSEC FORM 4 Code M—228,375 at $0.00filing
29 Jul 2022filed 2 Aug 2022F-star TherapeuticsSEC FORM 4 Code M$29K260,977 at $0.11filing
31 Mar 2022filed 4 Apr 2022F-star Therapeuticsoption or derivativeSEC FORM 4 Code A—126,909 at $0.00filing
9 Jan 2022filed 11 Jan 2022F-star Therapeuticsoption or derivativeSEC FORM 4 Code A—165,028 at $0.00filing
9 Mar 2021filed 11 Mar 2021F-star Therapeuticsoption or derivativeSEC FORM 4 Code A—127,924 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Nobody else traded the same names lately.